2008 Press Releases
 |
| 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|
- September 22, 2008: Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
- September 22, 2008: Tengion Announces Expanded European Orphan Medicinal Product Designation for Neo-Bladder Augment
- September 19, 2008: Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
- September 18, 2008: Tengion Scientists Publish Positive Preclinical Findings with Neo-Organ Demonstrating Long-term Durability and Growth with Skeletal Maturation
- July 23, 2008: Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
- June 30, 2008: Tengion Ceo Dr. Steven Nichtberger Wins Ernst & Young Greater Philadelphia Entrepreneur of The Year® Award
- June 12, 2008: Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration vs. Repair
- June 11, 2008: Tengion Named One of the Best Places to Work in Industry by The Scientist Magazine
- May 19, 2008: Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement™
- May 12, 2008: Tengion to Present Preclinical Data For Regeneration of Entire Bladder
- April 14, 2008: Tengion Appoints David P. Holveck to its Board of Directors
Investor Resources
| TNGN(Common Stock) |
|
| What's New |
| September 22, 2008 Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
| |
| September 22, 2008 Tengion Announces Expanded European Orphan Medicinal Product Designation for Neo-Bladder Augment
|
Investor Tool Kit
 | Print Page |
 | E-mail Page |
 | RSS Feeds |
 | E-mail Alerts |
 | IR Contact |